Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
15
|
pubmed:dateCreated |
1994-9-12
|
pubmed:abstractText |
The synthesis and biological activity of a series of seco-oxysterol analogs designed to be inhibitors of transcription of the gene for 3-hydroxy-3-methylglutaryl-Coenzyme A reductase (HMGR) are described. The compound possessing the most significant activity, [1 alpha (E),4 beta]-3-[2-(4- hydroxy-1-methylcyclohexyl)ethenyl]-alpha,alpha-dimethylbenzenepentan ol (4, U-88156), inhibited (IC50 = 10 microM) the expression of beta-galactosidase (beta-gal) in a transfected human HepG2 cell line wherein the beta-gal gene was driven by a 5 kB segment of the promoter for hamster HMGR. Furthermore, using wild-type HepG2 cells, it was shown that 10 microM 4 reduced HMGR mRNA levels by 73% while stimulating LDL-receptor activity by 47%. In the same system, the related oxysterol, 25-hydroxycholesterol (1), at 10 microM lowered both HMGR mRNA levels and LDL-receptor activity by 58% and 64%, respectively. Overall HMGR activity in wild-type HepG2 cells was inhibited 30% by 4 at 10 microM. These findings collectively demonstrate that a seco-oxysterol analog is capable of regulating HMGR gene expression and that this regulation can occur without a concomitant attenuation of the level of LDL-receptor activity.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0022-2623
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
22
|
pubmed:volume |
37
|
pubmed:geneSymbol |
HMGR
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2343-51
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:8057282-Animals,
pubmed-meshheading:8057282-Cricetinae,
pubmed-meshheading:8057282-Drug Design,
pubmed-meshheading:8057282-Gene Expression Regulation, Enzymologic,
pubmed-meshheading:8057282-Humans,
pubmed-meshheading:8057282-Hydroxymethylglutaryl CoA Reductases,
pubmed-meshheading:8057282-Oxygen,
pubmed-meshheading:8057282-Promoter Regions, Genetic,
pubmed-meshheading:8057282-Receptors, LDL,
pubmed-meshheading:8057282-Sterols,
pubmed-meshheading:8057282-Transcription, Genetic,
pubmed-meshheading:8057282-Tumor Cells, Cultured
|
pubmed:year |
1994
|
pubmed:articleTitle |
Design and synthesis of seco-oxysterol analogs as potential inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase gene transcription.
|
pubmed:affiliation |
Upjohn Laboratories, Upjohn Company, Kalamazoo, Michigan 49001.
|
pubmed:publicationType |
Journal Article
|